Risk factors for leg ulcer recurrence: a randomized trial of two types of compression stocking

Age and Ageing
P J FranksC J Moffatt

Abstract

Patients with recently healed leg ulceration were entered into a study of leg ulcer recurrence. In all, 188 patients [69% women, mean age = 72 (SD = 12) years] were entered into the study, of whom 166 were considered suitable for ready-made stockings and were randomized to one of two class II below-knee compression stockings and followed for at least 18 months. The remaining patients required either made-to-measure stockings (5) or could not tolerate stockings owing to friable skin and were treated by other methods (17). Overall cumulative recurrence rate was 26% after 1 year and 31% at 18 months. Independent risk factors for (RR = 2.34, p = 0.021) and unsuitability for stockings (RR = 2.52, p = 0.013). The randomized groups had similar stockings, 25 (15%) could not put their stockings on at all and 43 (26%) were only able to put them on with great difficulty. The two stocking types differed significantly in this regard when analysed for trend.

Citations

Nov 6, 2003·Orvosi hetilap·Tamás Sándor
Apr 24, 1999·The British Journal of Dermatology·H C Williams, A Rich
May 29, 2009·The New England Journal of Medicine·Seshadri Raju, Peter Neglén
Jun 6, 1998·BMJ : British Medical Journal·C J MorrellC G Brooker
Jun 5, 2004·BMJ : British Medical Journal·Deborah A SimonCharles N McCollum
Nov 3, 1997·Quality in Health Care : QHC·N CullumT A Sheldon
Jun 15, 2004·Advances in Skin & Wound Care·Ritesh N KumarDennis W Raisch
Jun 29, 2013·Journal des maladies vasculaires·A StansalP Priollet
Apr 1, 2013·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Seshadri RajuTamekia L Jones
Feb 3, 2009·International Journal of Nursing Studies·Kathleen FinlaysonMary Courtney
Jun 15, 2005·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Carmen BouzaJosé María Amate
May 3, 2006·International Wound Journal·Kathryn R Vowden, Peter Vowden
Apr 11, 2007·Journal of Clinical Nursing·Ann Van HeckeTom Defloor
Jun 19, 2016·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Seshadri RajuThomas F O'Donnell
May 12, 1998·Journal of Vascular Surgery·S RajuM Devidas
Apr 6, 2007·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·S R KulkarniK R Poskitt
Aug 26, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV
Sep 18, 2013·The International Journal of Lower Extremity Wounds·Suzanne KappLisa Donohue
Nov 8, 2006·The International Journal of Lower Extremity Wounds·Peter J Franks, Christine J Moffatt
May 6, 2005·The International Journal of Lower Extremity Wounds·Christine Moffatt
Feb 26, 2016·Phlebology·Robert R Attaran, Cassius I Ochoa Chaar
Apr 2, 1999·Vascular Medicine·S J PalfreymanJ A Michaels
Oct 12, 2017·Revista do Colégio Brasileiro de Cirurgiões·Guilherme Camargo Gonçalves de-AbreuJosé Luís Braga de-Aquino
Jun 3, 2016·The Cochrane Database of Systematic Reviews·Bin WuTing Xu
Oct 8, 2013·The Cochrane Database of Systematic Reviews·Nehemiah SamuelIan C Chetter
Sep 10, 2014·The Cochrane Database of Systematic Reviews·E Andrea Nelson, Sally E M Bell-Syer
Dec 7, 2018·British Journal of Community Nursing·Michelle Porter
Oct 26, 2018·The Korean Journal of Internal Medicine·Young Jin Youn, Juyong Lee
Sep 15, 2020·Journal of Wound Care·John C LantisAnthony Tickner
May 20, 2000·Journal of Wound Care·A D Taylor, R J Taylor
Sep 21, 2010·British Journal of Community Nursing·Annemarie Brown

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.